{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:14:10Z","timestamp":1790910850432,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,7]],"date-time":"2012-04-07T00:00:00Z","timestamp":1333756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00432-012-1194-2","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T23:09:52Z","timestamp":1333667392000},"page":"1355-1361","source":"Crossref","is-referenced-by-count":69,"title":["Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3"],"prefix":"10.1007","volume":"138","author":[{"given":"Bo","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,7]]},"reference":[{"key":"1194_CR1","doi-asserted-by":"crossref","first-page":"e10859","DOI":"10.1371\/journal.pone.0010859","volume":"5","author":"N Bar","year":"2010","unstructured":"Bar N, Dikstein R (2010) miR-22 foms a regulatory loop in PTEN\/AKT pathway and modulates signaling kinetics. PLoS One 5:e10859","journal-title":"PLoS One"},{"key":"1194_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"1194_CR3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642\u2013655","journal-title":"Cell"},{"key":"1194_CR4","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1073\/pnas.0409773102","volume":"102","author":"JA Engelman","year":"2005","unstructured":"Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC (2005) ErbB3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci USA 102:3788\u20133793","journal-title":"Proc Natl Acad Sci USA"},{"key":"1194_CR5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102\u2013114","journal-title":"Nat Rev Genet"},{"key":"1194_CR6","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1073\/pnas.1537685100","volume":"100","author":"T Holbro","year":"2003","unstructured":"Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF, Hynes NE (2003) The ErbB2\/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci USA 100:8933\u20138938","journal-title":"Proc Natl Acad Sci USA"},{"key":"1194_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Felay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"1194_CR8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","volume":"10","author":"VN Kim","year":"2009","unstructured":"Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126\u2013139","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1194_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1081\/CNV-67172","volume":"23","author":"JJ Laskin","year":"2005","unstructured":"Laskin JJ, Sandler AB (2005) State of the art in therapy for non-small cell lung cancer. Cancer Invest 23:427\u2013442","journal-title":"Cancer Invest"},{"key":"1194_CR10","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/MCB.01875-08","volume":"29","author":"DP Pandey","year":"2009","unstructured":"Pandey DP, Picard D (2009) miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 29:3783\u20133790","journal-title":"Mol Cell Biol"},{"issue":"70","key":"1194_CR11","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-09-3145","volume":"2010","author":"B Schoeberl","year":"2010","unstructured":"Schoeberl B, Faber AC, Li D, Liang MC, Crosby K, Onsum M, Burenkova O, Pace E, Walton Z, Nie L, Fulgham A, Song Y, Nielsen UB, Engelman JA, Wong KK (2010) An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation. Cancer Res 2010(70):2485\u20132494","journal-title":"Cancer Res"},{"key":"1194_CR12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ccr.2009.12.047","volume":"17","author":"Q Sheng","year":"2010","unstructured":"Sheng Q, Liu X, Fleming E, Yuan K, Piao H, Chen J, Moustafa Z, Thomas RK, Greulich H, Schinzel A, Zaghlul S, Batt D, Ettenberg S, Meyerson M, Schoeberl B, Kung AL, Hahn WC, Drapkin R, Livingston DM, Liu JF (2010) An activated ErbB3\/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. Cancer Cell 17:298\u2013310","journal-title":"Cancer Cell"},{"key":"1194_CR13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/carcin\/bgr081","volume":"32","author":"H Wang","year":"2011","unstructured":"Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W (2011) MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32:1033\u20131042","journal-title":"Carcinogenesis"},{"key":"1194_CR14","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1742-4658.2010.07594.x","volume":"277","author":"J Xiong","year":"2010","unstructured":"Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, Wu C, Zheng X, Du Q, Lin D, Liang Z (2010a) An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 277:1684\u20131694","journal-title":"FEBS J"},{"key":"1194_CR15","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/onc.2010.241","volume":"29","author":"J Xiong","year":"2010","unstructured":"Xiong J, Du Q, Liang Z (2010b) Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29:4980\u20134988","journal-title":"Oncogene"},{"key":"1194_CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.201010100","volume":"193","author":"D Xu","year":"2011","unstructured":"Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi R, Takata T, Shimamoto A, Ochiya T, Tahara H (2011) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193:409\u2013424","journal-title":"J Cell Biol"},{"key":"1194_CR17","doi-asserted-by":"crossref","first-page":"e20291","DOI":"10.1371\/journal.pone.0020291","volume":"6","author":"M Yamakuchi","year":"2011","unstructured":"Yamakuchi M, Yagi S, Ito T, Lowenstein CJ (2011) MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 6:e20291","journal-title":"PLoS One"},{"key":"1194_CR18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjc.6605895","volume":"103","author":"J Zhang","year":"2010","unstructured":"Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W (2010) microRNA-22, downregulated in heptocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 103:1215\u20131220","journal-title":"Br J Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1194-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-012-1194-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1194-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:40:37Z","timestamp":1559068837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-012-1194-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,7]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1007\/s00432-012-1194-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,7]]}}}